Skip to main content

Table 1 Distributions of age, gender, BMI, adiponectin and irisin levels, smoking and family history in the patient and control groups

From: The predictive effects of adiponectin and irisin hormones on diagnosis and clinical involvement of Sarcoidosis

 

Patient

Control

P

Age

49,78 ± 10,77

46,58 ± 8,80

0,132

BMI

28,94 ± 5,03

27,04 ± 4,78

0,074

Gender

  

0,247

 Female

64 (%71,1)

72 (%83,7)

 

 Male

26 (%28,9)

14 (%16,3)

 

Adiponectin

7,57 (6,26–10,12)

10,53(6,94–20,24)

0,094

Irisin

3,28 (2,99–3,98)

5,25 (3,29–9,44)

 < 0,001

Smoking

  

0,179

 Non-smoker

50 (%55,6)

48 (%55,8)

 

 Current-smoker

20 (%22,2)

30 (%34,9)

 Ex-smoker

20 (%22,2)

8 (%9,3)

Family history

  

0,875

 No

60 (%66,7)

54 (%62,8)

 

 Yes

30 (%33,3)

32 (%37,2)